Document is current
Any future updates will be listed below
-
Authors
Sage, Adam P.
Kim, Min Jung
Wong, Tiffany
Mak, Raymond
Erdle, Stephanie C.
Soller, Lianne
Chan, Edmond S.
- License Information
-
More Information
Article History
Received: 20 December 2024
Accepted: 11 March 2026
First Online: 29 March 2026
Declarations
:
: As this was a quality improvement project, it qualified for waiver for ethics from University of British Columbia/BC Children’s Hospital Research Ethics Board.
: Not applicable.
: ESC has participated in clinical trials for DBV Technologies, ALK-Abello, and RAPT Therapeutics; has been a member of advisory boards for ALK, Bausch Health, Celltrion, Incyte, Intrommune, Novartis, Sanofi, Viatris; and was co-lead of the CSACI oral immunotherapy guidelines.
